Commission on Human Medicines |This article relies on references
to primary sources. (March 2010)| The Commission on Human
Medicines (CHM) is a committee of the UK's Medicines and
Healthcare Products Regulatory Agency. It was formed in October
2005, and assumed the responsibilities of the Medicines
Commission and the Committee on Safety of Medicines. The CHM's
responsibilities include advising the UK government ministers on
matters relating to regulation of human medicinal products,
giving advice in relation to the safety, quality and efficacy of
human medicinal products, and promoting the collection and
investigation of information relating to adverse reactions for
human medicines. Background to the establishment  The Medicines
and Healthcare Products Regulatory Agency undertook a public
consultation on proposals to amend the advisory body structure
laid down in the Medicines Act 1968 in February 2005. Ministers
agreed to a new structure with the establishment of the
Commission that amalgamated the responsib